Centene Corporation (CNC)
NYSE: CNC · Real-Time Price · USD
60.04
-0.19 (-0.32%)
At close: Mar 28, 2025, 4:00 PM
60.16
+0.12 (0.20%)
After-hours: Mar 28, 2025, 8:00 PM EDT

Company Description

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States.

The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans.

This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans.

The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials.

The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services.

It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers.

The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Centene Corporation
Centene logo
Country United States
Founded 1984
IPO Date Dec 13, 2001
Industry Healthcare Plans
Sector Healthcare
Employees 60,500
CEO Sarah London

Contact Details

Address:
Centene Plaza, 7700 Forsyth Boulevard
Saint Louis, Missouri 63105
United States
Phone 314 725 4477
Website centene.com

Stock Details

Ticker Symbol CNC
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001071739
CUSIP Number 15135B101
ISIN Number US15135B1017
Employer ID 04-1406317
SIC Code 6324

Key Executives

Name Position
David P. Thomas Chief Executive Officer of Markets and Medicaid
Sarah M. London Chief Executive Officer and Director
Kenneth John Fasola President
Andrew Lynn Asher Executive Vice President and Chief Financial Officer
Christopher Andrew Koster Executive Vice President, General Counsel and Secretary
Susan R. Smith Chief Operating Officer
Katie Nicole Casso Senior Vice President of Finance, Corporate Controller and Chief Accounting Officer
Brian Phillip LeClaire M.B.A., Ph.D. Chief Information Officer
Jennifer Lynch Gilligan Senior Vice President of Investor Relations
Ashlee Knuckey Chief Risk, Ethics and Compliance Officer

Latest SEC Filings

Date Type Title
Mar 27, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 27, 2025 DEF 14A Other definitive proxy statements
Mar 21, 2025 144 Filing
Mar 12, 2025 8-K Current Report
Mar 5, 2025 8-K Current Report
Mar 3, 2025 8-K Current Report
Feb 24, 2025 8-K Current Report
Feb 18, 2025 10-K Annual Report
Feb 11, 2025 SCHEDULE 13G Filing
Feb 4, 2025 8-K Current Report